Scottish Brain Health Bioresource (EPAD and Prevent Dementia)
In order to understand and track early disease progression the European Prevention of Alzheimer’s Dementia (EPAD) consortium, the largest public-private partnership in the history of AD research, established a European-wide Longitudinal Cohort Study (LCS) that screened over 2,000 participants and collected a wide range of cognitive, clinical, neuroimaging and biomarker data. Although the EPAD LCS closed in 2019 the bioresource remains which contains over 100,000 samples including, blood products, saliva, urine and Cerebral Spinal Fluid (CSF), all collected from EPAD participants, which can be used to further our understanding of neurodegenerative disease. EPAD consent signed by the participants covers sample storage for at least 15 years and use by local (The University of Edinburgh and other scientists for additional research in the future. Also, information that could be obtained from the analysis of EPAD samples may be used scientifically and may be used in other research. The Bioresource has also recently added samples from the Prevent Dementia and EPAD Scotland studies and these will soon be available to researchers.
- Delusions in Alzheimer's disease (disorder)
Alexander Robertson Building
The Roslin Institute, University of Edinburgh
Easter Bush Campus
Last Updated: 21/03/2023
|Year||Access Requests Received||Access Requests Approved|